Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Drummond, A; Pichler, J; Argenziano, G; Zalaudek, I; Longo, C; Lallas, A; Piana, S; Moscarella, E.
Lichen planopilaris after imiquimod 5% cream for multiple BCC in basal cell naevus syndrome.
Australas J Dermatol. 2015; 56(4):e105-e107
Doi: 10.1111/ajd.12151
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Zalaudek Iris
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Basal cell naevus syndrome is an inherited autosomal dominant genetic disorder characterised by multiple basal cell carcinomas (BCC), skeletal, neurological and opthalmological abnormalities. The treatment of choice of the often multiple and large BCC consists of a combined approach including surgery, liquid nitrogen and other topical treatment modalities. Imiquimod 5% cream is an immune-response-modifying drug with antiviral and anti-tumour activity. Recent reports have associated the immune-stimulant properties of imiquimod with the exacerbation of several autoimmune skin diseases, such as eczema, psoriasis, vitiligo and lichenoid dermatitis. Here we report a patient with basal cell naevus syndrome who developed a lichen planopilaris on the same site of the scalp, which had been previously treated with two cycles of imiquimod for multiple BCC. © 2014 The Australasian College of Dermatologists.
- Find related publications in this database (using NLM MeSH Indexing)
- Alopecia - chemically induced
- Aminoquinolines - adverse effects
- Antineoplastic Agents - adverse effects
- Basal Cell Nevus Syndrome - drug therapy
- Drug Eruptions - etiology
- Female -
- Head and Neck Neoplasms - drug therapy
- Humans -
- Imiquimod -
- Lichen Planus - chemically induced
- Middle Aged -
- Scalp -
- Skin Cream - adverse effects
- Skin Neoplasms - drug therapy
- Find related publications in this database (Keywords)
- Gorlin-Goltz
- imiquimod 5%
- lichen planopilaris